Acute renal infarction is a rare, yet potentially devastating condition marked by the sudden interruption of blood supply to the renal parenchyma, often resulting in irreversible tissue damage.

Renal infarction in cardiac amyloidosis may not be as rare as previously thought, especially in patients with acute kidney injury (AKI), according to a French study recently published in the Mayo ...

Systemic amyloidosis is a major cause of renal injury, mostly due to direct kidney damage caused by deposits of abnormal protein called amyloid, in the kidney parenchyma. In patients with cardiac ...

Renal infarction is a rare condition affecting probably less than 0.007% of patients, although true incidence may be higher. 1 Patients typically present with flank pain, nausea, vomiting, and/or ...

"Chronic kidney disease (CKD), defined at a specific time point, is an important risk factor for cardiovascular disease," write Michael G. Shlipak, MD, MPH, from the San Francisco Veterans Affairs ...

LACTIC dehydrogenase is an enzyme that catalyzes the reversible conversion of pyruvic acid into lactic acid in the presence of the coenzyme dihydro-nicotinamide adenine dinucleotide (NAD.H 2): This ...

Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function. (HealthDay News) — Empagliflozin has kidney protective effects and reduces ...

Type 1 MI, Type 2 MI, and non-ischemic myocardial injury, as this affects diagnostic coding and reimbursement.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A study of 2,248 patients, most of whom ...

ABDOMINAL masses in the newborn infant are an intriguing medical phenomenon from the point of view of both diagnosis and selection of treatment. In a recent review by Melicow and Uson 1 of 372 cases ...

Compared with baseline, by 24 months, the estimated glomerular filtration rate was similar in the empagliflozin group, but decreased in the placebo group. HealthDay News — Empagliflozin has kidney ...